| 00110-V |
HIV_1 tat recombinant antigen full length 15 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00111-V |
HIV_1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV_1 gag region 39 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00112-V |
HIV_1 nef recombinant antigen a.a 3 to a.a 190 of the HIV_1 nef region 20 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00113-V |
HIV_1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV_1 env region 32 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00114-V |
HIV _2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV_2 env region 34 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00115-V |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00115-V-B |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00115-V-F |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00115-V-R |
HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00116-V |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. |
100 µg |
359.52 € |
- |
Virogen |
| 00116-V-B |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00116-V-F |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00116-V-R |
HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. |
100 µg |
389.05 € |
- |
Virogen |
| 00117-V |
HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00120-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa |
100 µg |
358.24 € |
- |
Virogen |
| 00121-V |
HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa |
100 µg |
359.52 € |
- |
Virogen |
| 00122-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant |
100 µg |
359.52 € |
- |
Virogen |
| 00123-V |
HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity |
100 µg |
359.54 € |
- |
Virogen |
| 00124-V |
HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant |
100 µg |
359.52 € |
- |
Virogen |
| 00131-V |
HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. |
100 µg |
359.52 € |
- |
Virogen |
| 00132-V |
HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. |
100 µg |
359.54 € |
- |
Virogen |
| 00133-V |
HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. |
100 µg |
359.52 € |
- |
Virogen |
| 00141-V |
T. Pallidum recombinant antigen p15 (full length) |
100 µg |
359.52 € |
- |
Virogen |
| 00142-V |
T. Pallidum recombinant antigen p17 (full length) |
100 µg |
359.54 € |
- |
Virogen |
| 00143-V |
T. Pallidum recombinant antigen p45 (full length) |
100 µg |
359.52 € |
- |
Virogen |
| 00144-V |
T. Pallidum recombinant antigen TmpA (full length) |
100 µg |
359.52 € |
- |
Virogen |
| 00150-V |
HCV core 2_119aa recombinant antigen. Genotypes available 1a, 1b, 2a, 2b, 3a, 3b, 3_10, 4, 5, 6a |
100 µg |
359.52 € |
- |
Virogen |
| 00151-V |
HCV core 24 antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00152-V |
HCV core recombinant antigen a.a.105_302 |
100 µg |
359.54 € |
- |
Virogen |
| 00153-V |
HCV NS3 1192_1456aa recombinant antigen a.a.1192_1459. Available genotypes 1a, 1b, 2b, 2c, 5, 6a |
100 µg |
359.52 € |
- |
Virogen |
| 00154-V |
HCV NS3 1359_1456aa antigen. The protein contains immunodominant regions (1359_1456aa). available genotypes 1a, 1b, 2b, 3, 4, 5, 6 |
100 µg |
359.52 € |
- |
Virogen |
| 00155-V |
HCV NS4 mosaic recombinant antigen a.a1691_1710, 1712_1733, 1921_1940. Genotypes available 1, 2, 3, 5. |
100 µg |
359.54 € |
- |
Virogen |
| 00156-V |
HCV NS4 1916_1947aa recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00157-V |
HCV NS5 2061_2302aa recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00158-V |
HCV NS5 2212_2313aa recombinant antigen. Available genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. |
100 µg |
359.52 € |
- |
Virogen |
| 00159-V |
HAV VP1_P2A recombinant antigen a.a. 722_830. |
100 µg |
359.52 € |
- |
Virogen |
| 00160-V |
HAV VP4_VP2 recombinant antigen a.a. 55_164. |
100 µg |
359.52 € |
- |
Virogen |
| 00161-V |
HAV P2C_P3A recombinant antigen a.a. 1492_1606. |
100 µg |
359.52 € |
- |
Virogen |
| 00162-V |
HAV P3C recombinant antigen a.a. 1643_1743. |
100 µg |
359.54 € |
- |
Virogen |
| 00163-V |
HAV VP3 recombinant antigen a.a. 304_415. |
100 µg |
359.52 € |
- |
Virogen |
| 00164-V |
HAV VP1_P2A recombinant antigen a.a. 669_782. |
100 µg |
359.52 € |
- |
Virogen |
| 00165-V |
HAV HAV P2C recombinant antigen a.a. 1121_1234. |
100 µg |
359.52 € |
- |
Virogen |
| 00166-V |
HAV P2C_P3A recombinant antigen a.a. 1392_1521. |
100 µg |
359.52 € |
- |
Virogen |
| 00167-V |
HDV Ag recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
| 00168-V |
HIV_1 p17_24_gp120_gp41 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
| 00169-V |
HIV_1 p17_24_gp120 antigen.The protein contains the HIV immunodominant regions from gag p17_p24 gp 120. |
100 µg |
359.54 € |
- |
Virogen |
| 00170-V |
HIV_1 gp41 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
| 00171-V |
HIV_1 gp41 Long recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
| 00172-V |
HIV_1 p17_p24 recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00173-V |
HIV_2 gp32 recombinant antigen. . |
100 µg |
359.54 € |
- |
Virogen |
| 00174-V |
HIV_1 p24 recombinant antigen. |
100 µg |
359.54 € |
- |
Virogen |
| 00175-V |
HIV 1, 2 envelope recombinant antigen. HIV_1 envelope conjugated to HIV_2 envelope peptide. |
100 µg |
359.54 € |
- |
Virogen |
| 00176-V |
HIV 1 envelope recombinant antigen. HIV_1 evnelope protein spanning the C_Terminus of gp 120 and most of gp 41. |
100 µg |
359.54 € |
- |
Virogen |
| 00177-V |
HIV 1 p24 core recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00178-V |
HIV type O envelope antigen. Synthetic HIV type_O peptide, containing the HIV type_O envelope_derived sequence. |
100 µg |
359.52 € |
- |
Virogen |
| 00179-V |
HIV _2 env gp36 recombinant antigen. a.a 390 to a.a 702. |
100 µg |
359.52 € |
- |
Virogen |
| 00180-V |
HIV 2 gp36 envelope antigen. Synthetic HIV_2 Peptide containing the HIV_2 specific sequence of gp36. |
100 µg |
359.54 € |
- |
Virogen |
| 00181-V |
HSV_1 gD recombinant antigen a.a. 266_394. |
100 µg |
359.52 € |
- |
Virogen |
| 00182-V |
HSV_2 gD recombinant antigen a.a. 266_394. |
100 µg |
359.54 € |
- |
Virogen |
| 00183-V |
HSV_2 gD recombinant antigen a.a. 525_578. |
100 µg |
359.54 € |
- |
Virogen |
| 00184-V |
HSV_1 gD recombinant antigen a.a. 84_175. |
100 µg |
359.54 € |
- |
Virogen |
| 00185-V |
CMV Pp65 (UL83) recombinant antigen (full length) |
100ug |
297.89 € |
- |
Virogen |
| 00186-V |
CMV Pp150 recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
| 00187-V |
CMV gB-AD1 (UL55) recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
| 00188-V |
CMV Pp65 (UL83) recombinant antigen a.a. 297_510 |
100 µg |
359.54 € |
- |
Virogen |
| 00189-V |
CMV Pp52 (UL44) recombinant antigen |
100ug |
297.89 € |
- |
Virogen |
| 00191-V |
SARS_Associated Coronavirus E recombinant antigen a.a. 1_76. |
100 µg |
359.54 € |
- |
Virogen |
| 00192-V |
SARS_Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1_49. |
100 µg |
359.54 € |
- |
Virogen |
| 00193-V |
SARS_Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340_390. |
100 µg |
359.54 € |
- |
Virogen |
| 00194-V |
SARS_Associated Coronavirus M recombinant antigen a.a. 182_216. |
100 µg |
359.54 € |
- |
Virogen |
| 00195-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12_53_90_115_171_203. |
100 µg |
359.52 € |
- |
Virogen |
| 00196-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408_470_540_573. |
100 µg |
359.54 € |
- |
Virogen |
| 00197-V |
SARS_Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051_1076_1121_1154_1162_1190. |
100 µg |
359.52 € |
- |
Virogen |
| 00198-V |
HIV_1 reverse transcriptase recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00199-V |
HIV_1 intergase antigen. The protein contains the HIV_1 immunodominant regions from pol protein (integrase). |
100 µg |
359.54 € |
- |
Virogen |
| 00200-V |
VZV gE recombinant antigen a.a. 48_135. |
100 µg |
359.52 € |
- |
Virogen |
| 00201-V |
VZV ORF9 recombinant antigen a.a. 6_28_76_100. |
100 µg |
359.52 € |
- |
Virogen |
| 00202-V |
VZV ORF26 recombinant antigen a.a. 9_33_184_208. |
100 µg |
359.54 € |
- |
Virogen |
| 00203-V |
HLTV_I envelope recombinant antigen. C_terminus of gp_46 and most of p21. |
100 µg |
359.54 € |
- |
Virogen |
| 00204-V |
HLTV_I p24 core recombinant antigen. |
100 µg |
359.52 € |
- |
Virogen |
| 00205-V |
HTLV_1 virus mosaic recombinant antigen a.a. 374_400_190_207. |
100 µg |
359.54 € |
- |
Virogen |
| 00206-V |
Toxoplasma gondii MIC 3 recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
| 00207-V |
Toxoplasma gondii P24 (GRA1) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
| 00208-V |
Toxoplasma gondii P29 (GRA7) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
| 00209-V |
Toxoplasma gondii P30 (SAG1) recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
| 00211-V |
HHV_4 recombinant p18 antigen Region 1_119aa |
100 µg |
359.52 € |
- |
Virogen |
| 00212-V |
HHV_4 recombinant mosaic EBNA1 antigen. Region 1_90_408_498aa |
100 µg |
359.54 € |
- |
Virogen |
| 00213-V |
HHV_4 recombinant EA antigen. Region 306_390aa |
100 µg |
359.54 € |
- |
Virogen |
| 00214-V |
Tick_born encephalitis virus gE recombinant antigen |
100 µg |
359.52 € |
- |
Virogen |
| 00215-V |
Rubella virus E1 mosaic recombinant antigen a.a. 157_176_374_390_213_239. |
100 µg |
359.52 € |
- |
Virogen |
| 00216-V |
Rubella virus E2 recombinant antigen a.a. 31_105. |
100 µg |
359.52 € |
- |
Virogen |
| 00217-V |
Rubella virus capsid (C) recombinant antigen a.a. 1_123. |
100 µg |
359.52 € |
- |
Virogen |
| 00401-V |
West Nile Virus Envelope recombinant antigen_Immunodominant region |
100 µg |
359.52 € |
- |
Virogen |
| 00402-V |
West Nile Virus Pre_M recombinant antigen_Immunodominant region |
100 µg |
359.54 € |
- |
Virogen |
| 00403-V |
West Nile Virus Envelope full length recombinant antigen 42 kDa region |
100 µg |
359.54 € |
- |
Virogen |
| 00700-V |
HTLV_1 gp21 recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
| 00701-V |
HTLV_1 gp46 recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
| 00900-V |
Allergens, Phospholipase A2 P00630 Bee Venom Recombinant Protein |
100ug/vial |
277.34 € |
- |
Virogen |
| 00901-V |
Allergens, Soy Bean p34 Recombinant protein |
100ug/vial |
277.73 € |
- |
Virogen |
| 011-A |
anti_GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. |
100 µg |
359.52 € |
- |
Virogen |
| 0114-A |
anti_HIV_2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
| 0116-A |
anti_HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115_V, protein. |
100 µg |
359.54 € |
- |
Virogen |
| 0117-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115_V, protein. |
100 µg |
359.54 € |
- |
Virogen |
| 012-A |
anti_HIV_1 p24 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 013-A |
anti_HIV_1 p55_17 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
| 014-A |
anti_HIV_1 p17 IgG1 (monoclonal) Produced against a recombinant protein |
100 µg |
359.52 € |
- |
Virogen |
| 015-A |
anti_HIV_1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 016-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 017-A |
anti_HCV core IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 018-A |
anti_HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
| 019-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.52 € |
- |
Virogen |
| 020-A |
anti_HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate |
100 µg |
359.52 € |
- |
Virogen |
| 021-A |
anti_HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. |
100 µg |
359.54 € |
- |
Virogen |
| 022-A |
anti_HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. |
100 µg |
359.52 € |
- |
Virogen |
| 023-A |
anti_HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. |
100 µg |
359.52 € |
- |
Virogen |
| 024-A |
anti_HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. |
100 µg |
359.52 € |
- |
Virogen |
| 025-A |
anti_Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus |
100 µg |
359.52 € |
- |
Virogen |
| 026-A |
anti_Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus |
100 µg |
359.54 € |
- |
Virogen |
| 027-A |
anti_Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. |
100 µg |
359.54 € |
- |
Virogen |
| 028-A |
anti_TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. |
100 µg |
359.54 € |
- |
Virogen |
| 029-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 030-A |
anti-HBcAg core IgM (monoclonal) |
100ug |
297.89 € |
- |
Virogen |
| 031-A |
anti_HBsAg pre_surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
100 µg |
359.52 € |
- |
Virogen |
| 032-A |
anti_HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. |
100 µg |
359.54 € |
- |
Virogen |
| 033-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 70 – 80 a.a. |
100 µg |
359.54 € |
- |
Virogen |
| 034-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 135_140 a.a. |
100 µg |
359.54 € |
- |
Virogen |
| 035-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 141_154 a.a. |
100 µg |
359.54 € |
- |
Virogen |
| 036-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 1_10 a.a. |
100 µg |
359.54 € |
- |
Virogen |
| 037-A |
anti_HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope 138_ 145 a.a. |
100 µg |
359.52 € |
- |
Virogen |
| 038-A |
anti_HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope 130_140 a.a. |
100 µg |
359.54 € |
- |
Virogen |
| 039-A |
anti_FAS IgG1 (monoclonal) Produced against a recombinant protein. |
100 µg |
359.54 € |
- |
Virogen |
| 041-A |
anti-Thyroxine monoclonal antibody IgG2a |
100ug |
297.89 € |
- |
Virogen |
| 049-A |
anti_FAS IgM (monoclonal) |
100 µg |
359.54 € |
- |
Virogen |
| 059-A |
anti_SLAM anti_CDw150 IgG2a (monoclonal) Produced against an activated B cell line. |
100 µg |
359.54 € |
- |
Virogen |
| 060-A |
anti_CD3 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 061-A |
anti_CD4 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 062-A |
anti_CD8 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 063-A |
anti_CD16 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 064-A |
anti_CD20 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 065-A |
anti_CD22 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 066-A |
anti_p53, clone BP53_12 |
100 µg |
359.54 € |
- |
Virogen |
| 067-A |
anti_CD45 RA IgG2 monoclonal antibody |
100 µg |
359.52 € |
- |
Virogen |
| 068-A |
anti_CD54 IgG2b_k monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 069-A |
anti_CD37 IgG2b (monoclonal) Produced against a B cell line. |
100 µg |
359.54 € |
- |
Virogen |
| 071-A |
anti_CD19 IgG1 monoclonal antibody |
100 µg |
359.52 € |
- |
Virogen |
| 079-A |
anti_Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. |
100 µg |
359.54 € |
- |
Virogen |
| 089-A |
anti_CD66e IgG1 monoclonal antibody |
100 µg |
359.54 € |
- |
Virogen |
| 101-A |
anti_Glutathione monoclonal antibody IgG1 |
100 µg |
277.34 € |
- |
Virogen |
| 102-A |
anti_Cysteine monoclonal antibody IgG1 |
100 µg |
359.54 € |
- |
Virogen |
| 131-A |
anti_RhoD human antigen IgG1 |
100 µg |
359.54 € |
- |
Virogen |
| 132-A |
anti_A1, A2 human blood antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
| 133-A |
anti_A1, A2, A3 human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 134-A |
anti_B human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 135-A |
anti_AB human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 136-A |
anti_Rh(o)D human antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 137-A |
anti_Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 |
100 µg |
359.54 € |
- |
Virogen |
| 138-A |
anti_RhoC human Rhesus system antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
| 139-A |
anti_A1, A2 human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 140-A |
anti_B human blood group antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 141-A |
anti_H n_ab human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 142-A |
anti_H ab human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 143-A |
anti_H inh human blood antigen IgM |
100 µg |
359.54 € |
- |
Virogen |
| 144-A |
anti_M human blood antigen IgM |
100 µg |
359.52 € |
- |
Virogen |
| 145-A |
anti_N human blood antigen Ig2b |
100 µg |
359.54 € |
- |
Virogen |
| 146-A |
Antiglobulin (COOMBS) Rabbit polyclonal |
100 µg |
359.54 € |
- |
Virogen |
| 199-A |
anti_HCV NS5a rabbit (polycnonal) Produced against a recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
| 216-A |
anti_HCV core IgG1 (monoclonal)Produced against recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
| 245-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 |
100 µg |
359.54 € |
- |
Virogen |
| 246-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen |
100 µg |
359.54 € |
- |
Virogen |
| 247-A |
anti_HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 |
100 µg |
359.54 € |
- |
Virogen |
| 266-A |
anti_HCV NS5b rabbit (polycnonal)Produced against a recombinant protein |
100 µg |
359.54 € |
- |
Virogen |
| 276-A |
anti_HCV NS5a rabbit polyclonal antibody directed against genotype 2A |
100 µg |
359.54 € |
- |
Virogen |
| 3001-V |
Prostatic pacid hosphatase _ full length (human) |
100 ug/vial |
289.46 € |
- |
Virogen |
| 3002-V |
Ovine Prolactin |
100 ug/vial |
289.46 € |
- |
Virogen |
| 501-A |
anti_CD3 T_cell |
100 µg |
359.54 € |
- |
Virogen |
| 502-A |
anti_CD4 T helper cells |
100 µg |
359.52 € |
- |
Virogen |
| 503-A |
anti_CD5 All T_cells |
100 µg |
359.52 € |
- |
Virogen |
| 504-A |
anti_CD7 All T_cells |
100 µg |
359.54 € |
- |
Virogen |
| 505-A |
anti_CD8 T cytotoxic_supressor cells |
100 µg |
359.54 € |
- |
Virogen |
| 506-A |
anti_CD10 Lymphoblasts |
100 µg |
359.52 € |
- |
Virogen |
| 507-A |
anti_CD16 NK_cells, monocytes, granulocytes |
100 µg |
359.52 € |
- |
Virogen |
| 508-A |
anti_CD18 Leucocytes |
100 µg |
359.52 € |
- |
Virogen |
| 509-A |
anti_CD20 B_lymphocytes |
100 µg |
359.54 € |
- |
Virogen |
| 510-A |
anti_CD22 B_lymphocytes |
100 µg |
359.54 € |
- |
Virogen |
| 511-A |
anti_CD25 IL_2 receptor expressed on activated T and B cells |
100 µg |
359.54 € |
- |
Virogen |
| 512-A |
anti_CD26 Activated T, B lymphocytes and macrophages |
100 µg |
359.54 € |
- |
Virogen |
| 513-A |
anti_CD34 Hematopoietic precursor cells |
100 µg |
359.52 € |
- |
Virogen |
| 514-A |
anti_CD38 Hematopoietic precursors, thymocytes, activated T_cells, plasma cells |
100 µg |
359.54 € |
- |
Virogen |
| 515-A |
anti_CD45 Leukocytes |
100 µg |
359.52 € |
- |
Virogen |
| 516-A |
anti_CD45 RA B_cells, T_cells, NK_cells |
100 µg |
359.54 € |
- |
Virogen |
| 517-A |
anti_ICAM_3, Leukocytes |
100 µg |
359.54 € |
- |
Virogen |
| 518-A |
anti_Transferrin receptor on activated T_B_, cells |
100 µg |
359.54 € |
- |
Virogen |
| 519-A |
anti_FAS antigen |
100 µg |
359.54 € |
- |
Virogen |
| 520-A |
anti_HLA_DR |
100 µg |
359.54 € |
- |
Virogen |
| 521-A |
anti_HLA_ABC on all Leukocytes |
100 µg |
359.54 € |
- |
Virogen |
| 522-A |
anti_IgM Heavy chain expressed on B cells |
100 µg |
359.54 € |
- |
Virogen |
| 523-A |
anti_Cortical thymocytes |
100 µg |
359.54 € |
- |
Virogen |
| 900-V |
Allergens, Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. |
100ug/vial |
277.73 € |
- |
Virogen |
| 901-V |
Allergens, Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. |
100ug/vial |
277.34 € |
- |
Virogen |